Avidity of IgG antibodies distinguishes primary from non-primary cytomegalovirus infection in pregnant women

被引:69
作者
Bodeus, M [1 ]
Feyder, S [1 ]
Goubau, P [1 ]
机构
[1] Univ Catholique Louvain, Dept Microbiol, Virol Unit, B-1200 Brussels, Belgium
来源
CLINICAL AND DIAGNOSTIC VIROLOGY | 1998年 / 9卷 / 01期
关键词
avidity index; HCMV; pregnancy;
D O I
10.1016/S0928-0197(97)10016-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Human cytomegalovirus (HCMV) is the most common cause of viral intrauterine infection. Fetal damage is mostly linked to maternal primary infection. It is therefore important to differentiate primary from non-primary infection in pregnant females. IgM tests often used for this purpose are not reliable enough. Objective: To evaluate an HCMV-IgG urea-elution assay for its ability to distinguish primary from non-primary infection. In this assay, soaking the antigen-antibody complex with an urea containing solution frees antibodies with low avidity but has no influence on those with high avidity. An avidity index (AI) was calculated: AI = (OD with urea/OD without urea) x 100. Study design: HCMV-IgG avidity was measured on a single serum of 79 patients with past infection (pregnant women, graft recipients and blood donors) and of 63 patients (78 sera) with documented seroconversion (pregnant women and graft recipients). Sixty-one pregnant women positive or equivocal for HCMV-IgM but without a documented seroconversion were included in this study. Results: Most (72/79) of the patients with past infection had an AI > 65% and all but one had an AI > 50%. In pregnant women, in the case of a primary infection within the past 3 months, AI are usually (51/53)< 50% and never > 65%. Among the IgM positive pregnant women who lack a seroconversion history, 38 had AI > 65% suggestive of an infection that had occured at least 3 months earlier, 11 had an AI in a grey area between 50 and 65% and 12 had an AI < 50%, suggestive of a recent primary infection. Conclusions: In pregnant women, measurement of the IgG avidity may help to date a HCMV infection, an AI > 65% highly suggests a past infection while an AI < 50% corresponds to a recent primary infection. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 22 条
[1]   AVIDITIES OF IGG DIRECTED AGAINST VIRAL CAPSID ANTIGEN OR EARLY ANTIGEN - USEFUL MARKERS FOR SIGNIFICANT EPSTEIN-BARR-VIRUS SEROLOGY [J].
ANDERSSON, A ;
VETTER, V ;
KREUTZER, L ;
BAUER, G .
JOURNAL OF MEDICAL VIROLOGY, 1994, 43 (03) :238-244
[2]   DIFFERENTIATION OF PRIMARY CYTOMEGALOVIRUS-INFECTION FROM REACTIVATION USING THE UREA DENATURATION TEST FOR MEASURING ANTIBODY AVIDITY [J].
BLACKBURN, NK ;
BESSELAAR, TG ;
SCHOUB, BD ;
OCONNELL, KF .
JOURNAL OF MEDICAL VIROLOGY, 1991, 33 (01) :6-9
[3]  
Dussaix E, 1996, PATHOL BIOL, V44, P405
[4]   THE OUTCOME OF CONGENITAL CYTOMEGALOVIRUS-INFECTION IN RELATION TO MATERNAL ANTIBODY STATUS [J].
FOWLER, KB ;
STAGNO, S ;
PASS, RF ;
BRITT, WJ ;
BOLL, TJ ;
ALFORD, CA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (10) :663-667
[5]   Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women [J].
GrangeotKeros, L ;
Mayaux, MJ ;
Lebon, P ;
Freymuth, F ;
Eugene, G ;
Stricker, R ;
Dussaix, E .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :944-946
[6]   DETECTION OF HUMAN PARVOVIRUS-B19-SPECIFIC IGM AND IGG ANTIBODIES USING A RECOMBINANT VIRAL VP1 ANTIGEN EXPRESSED IN INSECT CELLS AND ESTIMATION OF TIME OF INFECTION BY TESTING FOR ANTIBODY AVIDITY [J].
GRAY, JJ ;
COHEN, BJ ;
DESSELBERGER, U .
JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (01) :11-23
[7]   Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay [J].
Hashido, M ;
Inouye, S ;
Kawana, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (07) :1766-1768
[8]   MEASUREMENT OF AVIDITY OF SPECIFIC IGG FOR VERIFICATION OF RECENT PRIMARY RUBELLA [J].
HEDMAN, K ;
ROUSSEAU, SA .
JOURNAL OF MEDICAL VIROLOGY, 1989, 27 (04) :288-292
[9]   INDIRECT IMMUNOFLUORESCENCE TEST FOR DETECTION OF IGM ANTIBODIES TO CYTOMEGALO-VIRUS [J].
HEKKER, AC ;
BRANDSAATHOF, B ;
VIS, J ;
MEIJERS, RC .
JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (04) :596-600
[10]   SURVEILLANCE FOR CONGENITAL CYTOMEGALOVIRUS DISEASE - A REPORT FROM THE NATIONAL-CONGENITAL-CYTOMEGALOVIRUS-DISEASE-REGISTRY [J].
ISTAS, AS ;
DEMMLER, GJ ;
DOBBINS, JG ;
STEWART, JA ;
ADLER, S ;
BALE, JF ;
MURPH, J ;
BRADY, MT ;
CHERNESKY, MA ;
CHONMAITREE, T ;
COEN, RW ;
COURTNEY, J ;
DANKNER, WM ;
FORDJONES, EL ;
GARCIA, J ;
ATKINS, JT ;
GEHRZ, R ;
GIVNER, L ;
GRUBER, WC ;
KENNY, JF ;
KEYSERLING, HL ;
KINNEY, JS ;
KOVACS, A ;
KUMAR, ML ;
LEACH, CT ;
MARSHALL, GS ;
RABALAIS, G ;
MONTGOMERY, JR ;
MURPHY, D ;
PATAMASUCON, P ;
NEWPORT, MT ;
PASS, R ;
BOPPANA, SB ;
SHELTON, M ;
SOKOL, D ;
STAMOS, JK ;
ROWLEY, AH ;
STARR, S ;
WEINER, LB ;
GROSS, J ;
HUTTO, C ;
RUPAR, DG .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (03) :665-670